Viewing Study NCT06309589



Ignite Creation Date: 2024-05-06 @ 8:14 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06309589
Status: COMPLETED
Last Update Posted: 2024-03-13
First Post: 2024-03-01

Brief Title: The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary Cholangitis
Sponsor: YilihamuAbilitifu
Organization: Peoples Hospital of Xinjiang Uygur Autonomous Region

Study Overview

Official Title: Department of Infectious Diseases Peoples Hospital of Xinjiang Uygur Autonomous Region
Status: COMPLETED
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to compare in the effectiveness of combining ursodeoxycholic acid and vitamin D in treating patients with primary biliary cholangitis
Detailed Description: A prospective analysis will be conducted on 60 patients with primary PBC who were admitted to our Infectious Diseases Department and outpatient clinic All patients will take UDCA capsules orally and divide into two groups the experimental group which received UDCA combined with Vitamin D1200 IU per day treatment and the control group The control group will receive UDCA treatment alone for one year selected through a random number table method After one year the control group will be further divided into two groups using the same method One group will continue to receive UDCA alone while the other will receive a combination of UDCA and vitamin D for an additional year Clinical data clinical manifestations blood tests and imaging tests will be collected during the initial and subsequent treatments The efficacy will be evaluated using the Paris I and Barcelona standards

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None